CME Group financials
$263.22−0.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B | $1.53B | $1.49B | $1.44B | $1.34B |
| Gross profit | $1.71B | $1.88B | $1.65B | $1.54B | $1.69B | $1.64B | $1.53B | $1.58B | $1.53B | $1.49B | $1.44B | $1.34B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $1.11B | $1.31B | $1.02B | $972.6M | $1.13B | $1.11B | $947.1M | $1.02B | $1.00B | $959.6M | $863.2M | $820.2M |
| Net income | $1.04B | $1.17B | $1.17B | $896.6M | $1.03B | $944.2M | $863.7M | $901.3M | $872.1M | $844.4M | $804.3M | $740.8M |
| Net margin | 61.1% | 62.1% | 70.8% | 58.3% | 60.6% | 57.5% | 56.6% | 56.9% | 56.9% | 56.8% | 55.9% | 55.4% |
| Diluted EPS | $2.88 | $3.18 | $3.24 | $2.49 | $2.81 | $2.62 | $2.40 | $2.50 | $2.42 | $2.35 | $2.24 | $2.06 |
| EBITDA | $1.19B | $1.39B | $1.10B | $1.06B | $1.21B | $1.19B | $1.03B | $1.11B | $1.08B | $1.04B | $863.2M | $908.5M |
| Operating cash flow | $947.1M | $1.26B | $1.13B | $968.1M | $1.06B | $1.12B | $1.02B | $1.00B | $776.9M | $892.7M | $1.04B | $856.7M |
| Free cash flow | $923.5M | $1.24B | $1.10B | $949.7M | $1.04B | $1.10B | $991.7M | $973.2M | $758.7M | $872.9M | $1.02B | $836.8M |
| Diluted shares | 361.3M | 363.2M | 360.2M | 360.4M | 360.4M | 360.2M | 360.1M | 360.0M | 359.9M | 359.8M | 359.6M | 359.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.14B | $2.39B | $4.42B | $2.45B | $1.98B | $1.41B |
| Short-term investments | $131.4M | $124.2M | $125.0M | $123.2M | $117.6M | $113.9M |
| Total debt | $161.53B | $3.42B | $163.08B | $3.42B | $3.42B | $3.42B |
| Total assets | $194.68B | $201.99B | $198.42B | $187.14B | $179.91B | $157.83B |
| Total liabilities | $168.16B | $175.38B | $169.70B | $158.95B | $152.17B | $130.80B |
| Shareholders' equity | $26.52B | $26.62B | $28.73B | $28.19B | $27.74B | $27.03B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology